Schedule a consultation with IBI Healthcare today and take the first step toward achieving the significant weight loss youve been working toward.
Common side effects include: Headaches Flushing (a feeling of warmth in the face, neck, or chest) Upset stomach Nasal congestion Dizziness More serious side effects are rare but can occur
Approved by the MHRA in June 2026 as the first oral GLP-1 medicine licensed in the UK for weight loss, it is prescription-only, taken once daily on an empty stomach, and offered after clinical assessment against BMI-based eligibility as an adjunct to a reduced-calorie diet and increased physical activity
Tirzepatide is often a better fit for individuals with higher BMI or those who havent seen results with other weight loss drugs
Note: Please always seek guidance from both your physician and registered dietitian before beginning a GLP-1 agonist so that you can determine if it's appropriate and make the most informed decision for your health, lifestyle, and training goals
Draw dose: Remove needle cap